Controversial Italian COVID-19 IVDs Tender Must Not Be A Blueprint For The Future, Says Industry
Pooling of diagnostics resources should be preferred in the long-term
Executive Summary
Italy must ensure that ongoing efforts to tackle the coronavirus crisis do not rely on single suppliers, the country's medtech industry body said after DiaSorin looked likely to be the sole winner of a major COVID-19 diagnostics tender.
You may also be interested in...
Italy Boosts Per Capita Spend On Medtech, But Key Questions Hang Over Needs
The outlook for sustained COVID-19 recovery in Italy has cheered the medtech industry, but the private sector spend has contracted, and Italy’s imaging equipment is aging rapidly.
Brazilian Medtechs Leave Gloomy 2021 Far Behind As Exports Hit New High
Brazil's ABIMO medtech industry association reports newly-buoyant levels of export activity, as normal business routines crystalize further in the post-COVID phase. Meanwhile, member companies of the Brazil Health Devices initiative are outperforming industry averages.
Brazil Levels Medtech ICT Tariffs Playing Field
All medtech in Brazil will soon be subject to standardized industrial tariffs and development-related fiscal incentives, following a reform of rules relating to ICT across all industries.